Bavarian Nordic AS BAVA
News
'Mpox is not the new COVID,' says WHO, as it urges greater solidarity with Africa amid outbreak
Mpox vaccine maker's stock continues to surge
Bavarian Nordic Submits Data to EMA to Extend Mpox/Smallpox Vaccine Approval to Adolescents
Bavarian Nordic Announces FDA Acceptance and Priority Review of the BLA for its Chikungunya Vaccine
Bavarian Nordic Receives USD 156.8 Million from the U.S. Government for Additional Smallpox/Mpox Vaccine Production